Form D · Biotechnology
CEPHEID
Sunnyvale, CA · CIK 0001037760
Offering snapshot reported Jan 28, 2013 · SEC filing
- Reported sold
- $5.2M Offering amount: $5.2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 20, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 28, 2013 | Initial | $5,200,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-190894
Source: Form D, filed Jan 28, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John L. Bishop | Director, Executive |
| Thomas D. Brown | Director |
| Robert J. Easton | Director |
| Kerry Flom | Executive |
| Thomas L. Gutshall | Director |
| Cristina H. Kepner | Director |
| Andrew Miller | Executive |
| Dean Morton | Director |
| David H. Persing | Director, Executive |
| Hollings C. Renton | Director |
| Humberto Reyes | Executive |
| Joseph H. Smith | Executive |
| Glenn D. Steele | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
904 Caribbean Drive
Sunnyvale, CA, 94089
Sunnyvale, CA, 94089